| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 10/27/2004 | CN1541104A Method for inducing onset of reproductive cycle of female breeding animals |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1539460A Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method |
| 10/27/2004 | CN1539432A Granule of intermal dissolution for breast nodule |
| 10/27/2004 | CN1539420A Medicinal preparation of general alkaloid of bocconia cordata and producing method |
| 10/27/2004 | CN1539414A New medicinal preparation of sodium houttuynine sodium bisulfite and producing method |
| 10/27/2004 | CN1539410A Externally applied combined remedy for treating breast disease and preparation method |
| 10/27/2004 | CN1172950C Compound with breeding-resisting action and its prepn |
| 10/27/2004 | CN1172949C Testosterone derivative |
| 10/27/2004 | CN1172675C Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding |
| 10/27/2004 | CN1172664C Agent for lowering prolactin |
| 10/26/2004 | US6809116 Materials and methods for the treatment of depression |
| 10/26/2004 | US6809112 Administering a sexually therapeutically effective amount of a compound having the formula like (5r)-5-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinoline-2(1h)-thione |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | CA2395217C Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 10/26/2004 | CA2263888C Methods and compositions for the detection of cervical cancer |
| 10/26/2004 | CA2080462C Therapeutic uses of actin-binding compounds |
| 10/21/2004 | WO2004089951A1 Imidazopyridine derivatives having an affinity for melanocortin receptors |
| 10/21/2004 | WO2004089399A1 Novel uses of rfrp and ot7t022 |
| 10/21/2004 | WO2004089374A1 Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| 10/21/2004 | WO2004089278A2 Sexual hygienic composition |
| 10/21/2004 | WO2004076407A3 Pyrrolidine derivatives as oxytocin antagonists |
| 10/21/2004 | WO2003096980A3 Bicyclic modulators of androgen receptor function |
| 10/21/2004 | WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/21/2004 | US20040210080 3-(oxo, oxime, hydrazone, or alkylidene)-fluorene derivatives; can be synergistically combined with other anticarcinogenic, anticholesterol, anxiolytic agents, antidepressants or enzyme inhibitors; bone disorders |
| 10/21/2004 | US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 10/21/2004 | US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/21/2004 | US20040209934 Protein phosphate inhibitors |
| 10/21/2004 | US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine |
| 10/21/2004 | US20040209870 contain 5-HT ligands used to treat central nervous system disorders |
| 10/21/2004 | US20040209856 Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 10/21/2004 | US20040209832 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| 10/21/2004 | US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites |
| 10/21/2004 | US20040208941 Compositions for removal of toxins |
| 10/21/2004 | US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability |
| 10/21/2004 | US20040208851 Immunization by inoculation of DNA transcription unit |
| 10/21/2004 | CA2522231A1 Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| 10/21/2004 | CA2521855A1 Feminine hygiene composition comprising an equid milk extract |
| 10/21/2004 | CA2520855A1 Imidazopyridine derivatives as melanocortin receptor agonists |
| 10/20/2004 | EP1469077A1 Cell-specific expression/replication vector |
| 10/20/2004 | EP1468999A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 10/20/2004 | EP1468690A1 Use of estrogens for the treatment of infertility in male mammals |
| 10/20/2004 | EP1468110A2 Molecular signatures of commonly fatal carcinomas |
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 10/20/2004 | EP1467743A1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application |
| 10/20/2004 | EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 10/20/2004 | EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1467705A2 Therapeutic agent delivery tampon |
| 10/20/2004 | EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/20/2004 | EP1261588B1 IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | EP1043028B1 Phytase for preventing or treating mastitis |
| 10/20/2004 | EP0830136B1 New cryptophycins from synthesis |
| 10/20/2004 | CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 10/20/2004 | CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 10/20/2004 | CN1538956A Spiro compounds |
| 10/20/2004 | CN1538849A Use of long PENTRAXIN PTX 3 for treating female infertility |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1537617A Yi-E-Jing oral liquid contg. extractives of ant and silk moth |
| 10/20/2004 | CN1537616A Yi-E-Jing tablet contg. extractives of ant and silk moth for nourishing kidney and tonifying yang |
| 10/20/2004 | CN1537615A Yi-E-Jing capsule contg. extractives of ant and silk mouth |
| 10/20/2004 | CN1537614A Yi-E-Jing pill contg. extractives of ant and silk moth for tonifying yang |
| 10/20/2004 | CN1537613A Novel concentrated pill of wuji-Baifeng contg. black-bone chicken |
| 10/20/2004 | CN1537604A Traditional Chinese medicine Zaisheng pills for treating gynaecological disease |
| 10/20/2004 | CN1537570A Application of Ypsilandra herbs for preparing medicines for treating hemorrhagic diseases |
| 10/20/2004 | CN1537560A Medicine for treating monilia vaginitis |
| 10/20/2004 | CN1537542A Donkey-hide gelatin syrup |
| 10/20/2004 | CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171618C Healthy medicinal spirit for tonifying kidney and strengthening Yang |
| 10/20/2004 | CN1171612C Mixed Chinese medicine prepn. for treating natural miscrarriage and its preparation method |
| 10/20/2004 | CN1171601C Medicine for treating nephrosis and lung disease |
| 10/20/2004 | CN1171590C Minocycline vaginal gel |
| 10/19/2004 | US6806282 Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent |
| 10/19/2004 | US6805864 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 10/19/2004 | US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 10/14/2004 | WO2004087159A1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 10/14/2004 | WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 10/14/2004 | US20040204564 CRFR1 selective ligands |
| 10/14/2004 | US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists |
| 10/14/2004 | US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 10/14/2004 | US20040204456 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 10/14/2004 | US20040204449 New isoquinoline compounds |